bioAffinity Technologies annual total assets
2021
2022
2023
2024
2025
bioAffinity Technologies Total Assets Growth & History (BIAF)
bioAffinity Technologies's total assets was $11.0M for fiscal 2025.
View full bioAffinity Technologies company overviewbioAffinity Technologies annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.0M | $4.4M | +68.27% |
| 2024 | 2024-12-31 | $6.5M | −$1.7M | −20.77% |
| 2023 | 2023-12-31 | $8.2M | −$4.0M | −32.51% |
| 2022 | 2022-12-31 | $12.2M | $10.7M | +738.23% |
| 2021 | 2021-12-31 | $1.5M | — | — |
bioAffinity Technologies quarterly total assets
Q4.21
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7.6M | $2.9M | +60.37% |
| Q1 2026 | 2026-03-31 | $7.9M | $2.4M | +43.23% |
| Q4 2025 | 2025-12-31 | $11.0M | $4.4M | +68.27% |
| Q3 2025 | 2025-09-30 | $11.5M | $5.0M | +76.23% |
| Q2 2025 | 2025-06-30 | $4.8M | −$1.9M | −28.62% |
| Q1 2025 | 2025-03-31 | $5.5M | −$2.5M | −31.08% |
| Q4 2024 | 2024-12-31 | $6.5M | −$1.7M | −20.77% |
| Q3 2024 | 2024-09-30 | $6.6M | −$3.6M | −35.70% |
| Q2 2024 | 2024-06-30 | $6.7M | −$2.2M | −24.99% |
| Q1 2024 | 2024-03-31 | $8.0M | −$2.4M | −23.08% |
| Q4 2023 | 2023-12-31 | $8.2M | −$4.0M | −32.51% |
| Q3 2023 | 2023-09-30 | $10.2M | −$3.9M | −27.54% |
| Q2 2023 | 2023-06-30 | $8.9M | — | — |
| Q1 2023 | 2023-03-31 | $10.5M | — | — |
| Q4 2022 | 2022-12-31 | $12.2M | $10.7M | +738.23% |
| Q3 2022 | 2022-09-30 | $14.1M | — | — |
| Q4 2021 | 2021-12-31 | $1.5M | — | — |
bioAffinity Technologies total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, bioAffinity Technologies's total assets increased from $1.5M to $11.0M, a change of $9.5M. The latest reported quarter, Q2 2026, shows $7.6M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review bioAffinity Technologies source filings ↗